![](https://news.europawire.eu/wp-content/uploads/2024/02/Evonik-to-Introduce-New-Class-of-rPEG-Lipids-for-Enhanced-Immunogenicity-in-Drug-Delivery-144x144.jpg)
(IN BRIEF) Evonik has partnered with the University of Mainz to commercialize a new class of polyethylene glycols (PEGs) called randomized polyethylene glycols (rPEGs). These rPEGs will be integrated into Evonik’s specialized lipid platform for drug delivery in nucleic acid-based … Read the full press release